ATA596279A - Verfahren zur herstellung eines neuen inhibitors fuer angiotensinumwandelndes enzym - Google Patents

Verfahren zur herstellung eines neuen inhibitors fuer angiotensinumwandelndes enzym

Info

Publication number
ATA596279A
ATA596279A AT0596279A AT596279A ATA596279A AT A596279 A ATA596279 A AT A596279A AT 0596279 A AT0596279 A AT 0596279A AT 596279 A AT596279 A AT 596279A AT A596279 A ATA596279 A AT A596279A
Authority
AT
Austria
Prior art keywords
conversing
angiotensin
enzyme
producing
new inhibitor
Prior art date
Application number
AT0596279A
Other languages
English (en)
Other versions
AT390795B (de
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/064,897 external-priority patent/US4690937A/en
Priority claimed from US06/064,898 external-priority patent/US4690938A/en
Priority claimed from US06/064,902 external-priority patent/US4690940A/en
Priority claimed from US06/064,900 external-priority patent/US4690939A/en
Priority claimed from US06/064,903 external-priority patent/US4698355A/en
Priority claimed from US06/064,899 external-priority patent/US4698356A/en
Priority claimed from US06/064,901 external-priority patent/US4695577A/en
Application filed by Univ Miami filed Critical Univ Miami
Publication of ATA596279A publication Critical patent/ATA596279A/de
Application granted granted Critical
Publication of AT390795B publication Critical patent/AT390795B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT0596279A 1978-09-11 1979-09-10 Verfahren zur herstellung eines neuen inhibitors fuer angiotensinumwandelndes enzym AT390795B (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US94128978A 1978-09-11 1978-09-11
US95818078A 1978-11-06 1978-11-06
US06/064,897 US4690937A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,898 US4690938A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,902 US4690940A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,900 US4690939A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,903 US4698355A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,899 US4698356A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents
US06/064,901 US4695577A (en) 1979-08-14 1979-08-14 Anti-hypertensive agents

Publications (2)

Publication Number Publication Date
ATA596279A true ATA596279A (de) 1989-12-15
AT390795B AT390795B (de) 1990-06-25

Family

ID=27578299

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0596279A AT390795B (de) 1978-09-11 1979-09-10 Verfahren zur herstellung eines neuen inhibitors fuer angiotensinumwandelndes enzym

Country Status (15)

Country Link
EP (1) EP0009898B1 (de)
AT (1) AT390795B (de)
AU (1) AU532424B2 (de)
BG (1) BG34463A3 (de)
CS (1) CS242857B2 (de)
DE (1) DE2965443D1 (de)
DK (1) DK376179A (de)
FI (1) FI71749C (de)
GR (1) GR73585B (de)
HU (1) HU187258B (de)
IL (1) IL58223A (de)
IT (1) IT1193214B (de)
NZ (1) NZ191524A (de)
PH (1) PH19104A (de)
PT (1) PT70158A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids
PT70158A1 (en) * 1980-03-03 1982-03-01 Univ Miami Process for preparing anti-hypertensive agents
US4734420A (en) * 1980-03-05 1988-03-29 University Of Miami Anti-hypertensive agents
US4690936A (en) * 1980-03-05 1987-09-01 University Of Miami Anti-hypertensive agents
DE3161915D1 (en) * 1980-03-05 1984-02-23 Univ Miami Angiotensin converting enzyme inhibitors
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4512979A (en) * 1981-03-23 1985-04-23 Merck & Co., Inc. Dipeptides containing thialysine and related amino acids as antihypertensives
JPS57209270A (en) * 1981-06-19 1982-12-22 Chugai Pharmaceut Co Ltd Proline derivative
AT386603B (de) * 1981-06-19 1988-09-26 Chugai Pharmaceutical Co Ltd Verfahren zur herstellung von neuen prolinderivaten
HUT46044A (en) * 1986-11-21 1988-09-28 Richter Gedeon Vegyeszet Process for producing immunstimulant peptides inhibiting multiplication of leukaemic cells and pharmaceutics comprising same
CN1081650C (zh) * 1995-12-27 2002-03-27 罗纳-普朗克·维斯科苏希公司 缩聚物,尤其是聚酰胺6,6后冷凝的方法
WO2009151407A2 (en) 2008-06-14 2009-12-17 Veredus Laboratories Pte Ltd Influenza sequences

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4053651A (en) * 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension
US4116962A (en) * 1976-12-03 1978-09-26 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
US4091024A (en) * 1976-12-03 1978-05-23 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
AU518147B2 (en) * 1976-12-03 1981-09-17 E.R. Squibb & Sons, Inc. Derivatives of thiazolidine, thiazine and morpholine carboxylic acids
US4113715A (en) * 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
US4108886A (en) * 1977-03-11 1978-08-22 E. R. Squibb & Sons, Inc. Thiopropanoylamino acid derivatives

Also Published As

Publication number Publication date
PT70158A (en) 1979-09-30
IT7925612A0 (it) 1979-09-11
FI71749C (fi) 1987-02-09
IL58223A (en) 1984-01-31
DK376179A (da) 1980-03-12
GR73585B (de) 1984-03-26
CS615079A2 (en) 1985-08-15
AU5070579A (en) 1980-03-20
EP0009898B1 (de) 1983-05-18
IT1193214B (it) 1988-06-15
AU532424B2 (en) 1983-09-29
HU187258B (en) 1985-12-28
NZ191524A (en) 1982-12-07
BG34463A3 (en) 1983-09-15
CS242857B2 (en) 1986-05-15
DE2965443D1 (en) 1983-07-07
AT390795B (de) 1990-06-25
FI792806A (fi) 1980-03-12
PH19104A (en) 1986-01-02
FI71749B (fi) 1986-10-31
EP0009898A1 (de) 1980-04-16

Similar Documents

Publication Publication Date Title
AT385038B (de) Verfahren zur herstellung eines neuen inhibitors fuer das angiotensin umwandelnde enzym
ATA596279A (de) Verfahren zur herstellung eines neuen inhibitors fuer angiotensinumwandelndes enzym
AT387240B (de) Verfahren zur herstellung eines nicht-haftenden ueberzogenen stahlgegenstandes
AT354214B (de) Verfahren zur ablagerung bei einer glimment- ladung, sowie anordnung fuer die glimmentladung zur durchfuehrung des verfahrens
ATA91580A (de) Verfahren zur herstellung von arylessigsaeureestern
AT366063B (de) Verfahren zur gewinnung eines neuen glykoproteins
AT358203B (de) Verfahren zur herstellung von neuen als spezifische chromogene enzymsubstrate fuer serinproteasen geeigneten peptiden
ATA246378A (de) Verfahren zur herstellung eines hydraulischen bindemittels
AT383625B (de) Verfahren zur verfestigung eines faservlieses
DE3764617D1 (de) Verfahren zur reduktion eines nitrils zum entsprechenden alkohol.
ATA84079A (de) Verfahren zur verbesserung der konsistenz eines angemachten instant-puerees
AT370411B (de) Verfahren zur phlegmatisierung von wasserunl
AT363891B (de) Verfahren zur herstellung eines neuen peptidischen glykosidhydrolase-inhibitors
AT360509B (de) Verfahren zur herstellung von neuen racemischen oder optisch aktiven aminosaeuren
AT379158B (de) Verfahren zur ummantelung gerader rohrstuecke
AT363054B (de) Verfahren zur herstellung von inhibitoren fuer glykosid-hydrolasen aus bacillen
AT362081B (de) Verfahren zur durchfuehrung enzymatischer bestimmungen
AT378999B (de) Verfahren zur aufladung eines verdraengerverdichters
ATA122379A (de) Verfahren zur herstellung eines alpha-amylase- substrats
AT361905B (de) Verfahren zur racematspaltung von dl-alpha- aminocarbonsaeuren
ATA262079A (de) Verfahren zur herstellung von neuen n-acylierten aminosaeureestern
DD139300A1 (de) Verfahren zur bestimmung der restlebensdauer eines zeitstandbeanspruchten bauteiles
ATA727779A (de) Verfahren zur herstellung von neuen n-(pyridyl -2)-dithiocarbaminsaeureestern
DD138993A1 (de) Verfahren zur reinigung von vergasungsgas
DD135406A1 (de) Verfahren zur verminderung der korrosiven wirkung von eisen-iii-ionen auf stahl in sauren beizloesungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee